11-65086994-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006782.4(ZFPL1):c.548C>A(p.Ala183Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006782.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFPL1 | NM_006782.4 | c.548C>A | p.Ala183Asp | missense_variant | 6/8 | ENST00000294258.8 | NP_006773.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFPL1 | ENST00000294258.8 | c.548C>A | p.Ala183Asp | missense_variant | 6/8 | 1 | NM_006782.4 | ENSP00000294258.3 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000604 AC: 15AN: 248316Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134714
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461270Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 726940
GnomAD4 genome AF: 0.000256 AC: 39AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74424
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2024 | The c.548C>A (p.A183D) alteration is located in exon 6 (coding exon 5) of the ZFPL1 gene. This alteration results from a C to A substitution at nucleotide position 548, causing the alanine (A) at amino acid position 183 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at